UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

Acta neuropathologica communications, 2016-12, Vol.4 (1), p.130-130, Article 130

2016

Volltextzugriff (PDF)

UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11 C]PIB AND [18 F]FLUTEMETAMOL IMAGES FOR SUVR QUANTITATION ON THE CENTILOID SCALE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P126-P126

2016

Volltextzugriff (PDF)

PERFORMANCE OF [18F]FLUTEMETAMOL AMYLOID IMAGING AGAINST THE CURRENT (2012) NIA-AA RECOMMENDATIONS FOR THE NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P926-P926

2016

Volltextzugriff (PDF)

IC‐P‐173: Utility of PMOD Image Quantification Software for Processing [11C]PIB and [18F]Flutemetamol Images for SUVR Quantitation on The Centiloid Scale

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_2), p.P126-P126

2016

Volltextzugriff (PDF)

FLUTRICICLAMIDE ([18F]GE180) PET: FIRST IN HUMAN PET STUDY OF NOVEL IN VIVO MARKER OF HUMAN TRANSLATOR PROTEIN

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P397-P397

2016

Volltextzugriff (PDF)

Pons as an alternative reference region in [18F]flutemetamol quantification of amyloidosis

NeuroImage (Orlando, Fla.), 2010-08, Vol.52 (S1), p.S137-S137

2010

Volltextzugriff (PDF)

Subject classification from [18F]flutemetamol data into categories of raised or low levels of beta-amyloid: Concordance between quantitative and visual assessment

NeuroImage (Orlando, Fla.), 2010-08, Vol.52 (S1), p.S144-S144

2010

Volltextzugriff (PDF)

Visual Read Performance and Related Metrics of the Amyloid Imaging Agent [18 F]flutemetamol; Results from the Phase II Multicenter Trial

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S49-S50

2010

Volltextzugriff (PDF)

Assessing SUVR metrics for different PET cameras in amyloid imaging

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P51-P52

2009

Volltextzugriff (PDF)

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI

Alzheimer's & dementia, 2023-12, Vol.19 (S16), p.n/a

2023

Volltextzugriff (PDF)

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

2023

Volltextzugriff (PDF)

Concordance between visual read and quantification for categorisation of [18 F]Flutemetamol data into either normal or abnormal amyloid levels

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S71-S72

2010

Volltextzugriff (PDF)

IC‐P‐002: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_1), p.P14-P14

2019

Volltextzugriff (PDF)

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P1408-P1408

2019

Volltextzugriff (PDF)

P4‐306: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_27), p.P1408-P1408

2019

Volltextzugriff (PDF)

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P14-P14

2019

Volltextzugriff (PDF)

P2‐439: IDENTIFICATION OF FTD CANDIDATES IN MCI‐SNAP GROUPS BY CORTICAL THICKNESS ANALYSIS

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_16), p.P883-P883

2018

Volltextzugriff (PDF)

IDENTIFICATION OF FTD CANDIDATES IN MCI-SNAP GROUPS BY CORTICAL THICKNESS ANALYSIS

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P883-P883

2018

Volltextzugriff (PDF)

A novel regional centiloid atlas to investigate the relationship between the quantification of [18F]flutemetamol amyloid PET and CSF Aβ42/40 in patients with SCD or MCI

Alzheimer's & dementia, 2021-12, Vol.17 (S1), p.n/a

2021

Volltextzugriff (PDF)

Microglial activation evaluated using flutriciclamide (11F‐GE180) in subjects with cognitive impairment

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Microglial activation evaluated using flutriciclamide ( 11 F‐GE180) in subjects with cognitive impairment: Neuroimaging / Optimal neuroimaging measures for tracking disease progression

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

DETERMINING THE UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11C]PIB AND [18F]FLUTEMETAMOL IMAGES IN A PET-ONLY PIPELINE TO GENERATE SUVR FOR QUANTIFICATION ON THE CENTILOID SCALE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P11-P12

2017

Volltextzugriff (PDF)

SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER’S DISEASE NEUROPATHOLOGY SPECTRUM

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P1222-P1222

2019

Volltextzugriff (PDF)

F4‐03‐03: SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER'S DISEASE NEUROPATHOLOGY SPECTRUM

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_23), p.P1222-P1222

2019

Volltextzugriff (PDF)

IC‐P‐012: CONFOCAL ANALYSIS OF FLUORESCENT SIGNAL DERIVED FROM CN‐FLUTEMETAMOL LABELED DIFFUSE AND NEURITIC PLAQUES IN ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_1), p.P21-P21

2018

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(268)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(295)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11 C]PIB AND [18 F]FLUTEMETAMOL IMAGES FOR SUVR QUANTITATION ON THE CENTILOID SCALE

PERFORMANCE OF [18F]FLUTEMETAMOL AMYLOID IMAGING AGAINST THE CURRENT (2012) NIA-AA RECOMMENDATIONS FOR THE NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER'S DISEASE

IC‐P‐173: Utility of PMOD Image Quantification Software for Processing [11C]PIB and [18F]Flutemetamol Images for SUVR Quantitation on The Centiloid Scale

FLUTRICICLAMIDE ([18F]GE180) PET: FIRST IN HUMAN PET STUDY OF NOVEL IN VIVO MARKER OF HUMAN TRANSLATOR PROTEIN

Pons as an alternative reference region in [18F]flutemetamol quantification of amyloidosis

Subject classification from [18F]flutemetamol data into categories of raised or low levels of beta-amyloid: Concordance between quantitative and visual assessment

Visual Read Performance and Related Metrics of the Amyloid Imaging Agent [18 F]flutemetamol; Results from the Phase II Multicenter Trial

Assessing SUVR metrics for different PET cameras in amyloid imaging

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI

Concordance between visual read and quantification for categorisation of [18 F]Flutemetamol data into either normal or abnormal amyloid levels

IC‐P‐002: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

P4‐306: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS

P2‐439: IDENTIFICATION OF FTD CANDIDATES IN MCI‐SNAP GROUPS BY CORTICAL THICKNESS ANALYSIS

IDENTIFICATION OF FTD CANDIDATES IN MCI-SNAP GROUPS BY CORTICAL THICKNESS ANALYSIS

A novel regional centiloid atlas to investigate the relationship between the quantification of [18F]flutemetamol amyloid PET and CSF Aβ42/40 in patients with SCD or MCI

Microglial activation evaluated using flutriciclamide (11F‐GE180) in subjects with cognitive impairment

Microglial activation evaluated using flutriciclamide ( 11 F‐GE180) in subjects with cognitive impairment: Neuroimaging / Optimal neuroimaging measures for tracking disease progression

DETERMINING THE UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11C]PIB AND [18F]FLUTEMETAMOL IMAGES IN A PET-ONLY PIPELINE TO GENERATE SUVR FOR QUANTIFICATION ON THE CENTILOID SCALE

SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER’S DISEASE NEUROPATHOLOGY SPECTRUM

F4‐03‐03: SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER'S DISEASE NEUROPATHOLOGY SPECTRUM

IC‐P‐012: CONFOCAL ANALYSIS OF FLUORESCENT SIGNAL DERIVED FROM CN‐FLUTEMETAMOL LABELED DIFFUSE AND NEURITIC PLAQUES IN ALZHEIMER'S DISEASE

Suchergebnisse filtern